Africa Finance Corp President/CEO Samaila Zubairu
Africa Finance Corporation (AFC), the continent's leading infrastructure solutions provider, has successfully raised $400 million in a Shariah-compliant Commodity Murabaha facility. The move marks the firm's strategic return to the Islamic finance market for the first time in eight years. AFC's CEO Samaila Zubairu speaks with Bloomberg TV's Chief Africa correspondent Jennifer Zabasajja on Horizons Middle East and Africa to discuss the facility. (Source: Bloomberg)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
21 hours ago
- Business Insider
Short-Seller Chanos and Michael Saylor Argue Over Strategy Stock's (MSTR) Valuation
The war of words between famous short-seller Jim Chanos and Strategy's (MSTR) executive chairman, Michael Saylor, over the Bitcoin treasury company's premium valuation continues. In an interview with Bloomberg TV, Chanos called Saylor a 'wonderful salesman' and believes that Strategy, previously known as MicroStrategy, should not be valued only on the basis of its Bitcoin Holdings. Confident Investing Starts Here: Notably, Strategy has been accumulating Bitcoin by raising funds through equity or debt offerings to purchase the cryptocurrency. Interestingly, the company has shifted to selling preferred stock to fund its Bitcoin purchases, instead of convertible bonds or at-the-money common stock sales. Chanos Suggests that Traders Short Strategy Stock The debate between Chanos and Saylor was triggered when the former suggested that traders should short Strategy stock and purchase Bitcoin directly. Chanos explained that the premium enjoyed by MSTR stock over the value of Bitcoin holdings could narrow, presenting an opportunity for the arbitrage trade. Chanos thinks that Strategy's market value should not be more than the value of its Bitcoin holdings. For context, as of June 9, the company held 582,000 Bitcoins, worth around $62.3 billion, while MSTR stock's market value of $108 billion was over 1.7 times its crypto holdings. Chanos believes that this disconnect creates an arbitrage opportunity to buy the largest cryptocurrency and short MSTR stock. However, Saylor disagrees with the short seller's trading recommendation, saying, 'I don't think he understands what our business model is.' He highlighted that Strategy is the largest issuer of Bitcoin-backed credit instruments in the world. He added that Chanos still doesn't understand that MSTR is an operating company and not a closed-end trust or a holding company. While trusts can't leverage Bitcoin, issue preferred shares, and/or issue permanent shares, Strategy can do these. Chanos has previously called Saylor's tactics 'financial gibberish.' Saylor cautioned that if MSTR stock trades at a weak premium, the company is going to sell the preferred stock and buyback common shares, and if the stock rallies, Chanos is 'going to get liquidated and wiped out.' Is MSTR Stock a Buy, Sell, or Hold? Unlike Chanos, most Wall Street analysts are bullish on Strategy stock, with a Strong Buy consensus rating based on 12 Buys and one Sell recommendation. In addition, the average MSTR stock price target of $524.92 per share implies 37.1% upside potential.
Business Wire
a day ago
- Business Wire
Abstractive Health Launches Clinical Time Machine, the First AI Game Built on Real Historical Patient Records
NEW YORK--(BUSINESS WIRE)--Abstractive Health has launched Clinical Time Machine, an AI-driven simulation that immerses physicians in diagnostic cases using real historical medical charts. Built on the same HIPAA-compliant platform that powers live summarization of electronic health records (EHRs) in hospital settings, the simulation lets clinicians explore rare, complex cases from hundreds of years ago without patient risk. Abstractive Health's broader goal is to bring clinicians into meaningful, hands-on engagement with AI. Share CEO Vince Hartman calls it 'a Microsoft Flight Simulator for medicine,' enabling diagnostic training on authentic data with no need for EHR integration. 'Three years after ChatGPT, fewer than 1% of physicians have ever seen an AI full medical record summary,' he says. 'We're changing that.' Each case begins with an AI-generated summary distilled from original, centuries-old handwritten documents. Clinicians explore the structured chart, from history of present illness to labs and vitals, and receive simulated updates based on actual clinical observations. 'It's not a quiz. It's about engaging clinical reasoning in a sandbox where doctors can make decisions and learn from them,' Hartman explains. The simulation is built on Abstractive Health's existing summarization and retrieval-augmented generation (RAG) and agentic AI platform. Leveraging advanced OCR and a robust AI summarization pipeline, it can also process handwritten records and turn scribbled notes into readable clinical narratives. The summarization technology is currently being piloted at Weill Cornell Medicine in a research collaboration to assist with writing Emergency Medicine handoff notes. Abstractive Health is also preparing to roll out the experience to Canadian outpatient clinics through a partnership with Canada's WELL Health Technologies that followed an investment and distribution deal inked last year. Abstractive Health's broader goal is to bring clinicians into meaningful, hands-on engagement with AI. 'We're not just saving time - we're helping doctors think better,' Hartman says. 'This is about curiosity, growth, and elevating clinical skill.' Clinical Time Machine is available now through Abstractive's platform for free. About Abstractive Health Abstractive Health retrieves medical records, generates trusted AI summaries, and answers complex clinical questions. Its platform is used by clinicians nationwide and is currently in pilots with Well Health and Weill Cornell Medicine. A top 3 company in the 2024 VA AI Tech Sprint, Abstractive is backed by the NSF and has been featured by Forbes 30 Under 30.
Yahoo
a day ago
- Yahoo
Ford CEO says rare earths shortage forced it to halt production
Ford CEO Jim Farley said that a rare earth minerals shortage is hurting production and caused the automaker to temporarily shut down one of its plants last month, according to an interview with Bloomberg TV. Rare earth minerals, which are a set of 17 metallic elements, are integral to automobile production, and enable features like windshield wipers, seat belts and speakers to function. About 90% of the U.S.'s rare earth minerals come from China, the world's largest producer of rare earths, according to data from the Geological Survey. China has leveraged its grip on rare earths and their widespread utility amid a trade war with the U.S. In April, Beijing announced greater export controls on the materials — a sticking point in tariff negotiations — along with other retaliatory trade measures. The controls require businesses to apply for a license to export rare earths, which U.S. automakers say they have been struggling to secure. Earlier this week, on June 11, following two days of discussions in London, U.S. and Chinese negotiators struck an agreement under which Beijing would resume regular exports of rare earths to the U.S. "The centrality of rare earth export restrictions to the trade deal underscores the criticality of minerals to the U.S. economy as well as the severity of the chokehold Beijing holds on global supply chains," policy experts from the Center for Strategic and International Studies wrote in a research note. "Hand-to-mouth" Farley said the slowing flow of the critical minerals into the U.S. has presented a challenge for Ford. "It's day to day," he told Bloomberg TV Friday. "We have had to shut down factories. It's hand-to-mouth right now." Ford did not immediately respond to CBS MoneyWatch's request for comment. Ford Chief Financial Officer Sherry House addressed disruptions caused by new restrictions on rare earth minerals from China at a June conference. "There are many components that rare earth minerals are in. And any of those that are coming from China require you to now go through export control," she said. "And so there's an additional layer of administrative process that has to happen." The process isn't reliable, she added, noting that sometimes it goes "really smoothly," while other times applications are not approved quickly. "Most frequently, it goes through; it just may take more time," she said. For now, Ford is able to manage the cumbersome process, House said, but added that it has the potential to become a "larger issue for us." Farley also told the outlet that he is optimistic about the developments in trade talks between the U.S. and China, and hopes that rare earth supply constraints will ease soon. He added that Ford is awaiting approval of applications with China's Ministry of Commerce to export more rare earths. "We have applications into MOFCOM and they are being approved one at a time," Farley told Bloomberg TV. Video shows Air India plane crashing in Ahmedabad Air India plane crashes shortly after takeoff, carrying more than 240 people Israel ready to launch operation into Iran, U.S. officials say
